Frank Manganella
Corporate Officer/Principal chez NEXIEN BIOPHARMA, INC.
Profil
Frank Manganella is the founder and CEO of CH3 Partners LLC, which was founded in 2015.
He is also the founder of Ch3 Ventures.
Currently, he holds the position of Vice President-Corporate Development at Nexien BioPharma, Inc. since 2018 and the position of Chief Financial Officer & Managing Partner at CRx Bio Holdings LLC since 2017.
In the past, he worked as Managing Director & Head-FICC Sales at Commerzbank AG from 2011 to 2014.
Mr. Manganella received an MBA from Durham University Business School in 2013.
Postes actifs de Frank Manganella
| Sociétés | Poste | Début |
|---|---|---|
| NEXIEN BIOPHARMA, INC. | Corporate Officer/Principal | 30/10/2018 |
| CH3 Partners LLC | Directeur Général | 01/10/2015 |
CRx Bio Holdings LLC
 CRx Bio Holdings LLC Pharmaceuticals: OtherHealth Technology CRx Bio Holdings LLC engages in the research and development of advanced cannabinoid therapeutic formulations with the objective of enhancing the bioavailability, pharmacokinetics, and pharmacodynamics of cannabinoids. The company was founded by Alex Wasyl and is headquartered in Princeton, NJ. | Directeur Financier/CFO | 01/11/2017 |
| Ch3 Ventures | Fondateur | - |
Anciens postes connus de Frank Manganella
| Sociétés | Poste | Fin |
|---|---|---|
| COMMERZBANK AG | Corporate Officer/Principal | 01/06/2014 |
Formation de Frank Manganella
| Durham University Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COMMERZBANK AG | Finance |
| NEXIEN BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
CRx Bio Holdings LLC
CRx Bio Holdings LLC Pharmaceuticals: OtherHealth Technology CRx Bio Holdings LLC engages in the research and development of advanced cannabinoid therapeutic formulations with the objective of enhancing the bioavailability, pharmacokinetics, and pharmacodynamics of cannabinoids. The company was founded by Alex Wasyl and is headquartered in Princeton, NJ. | Health Technology |
| CH3 Partners LLC | |
| Ch3 Ventures |
